However, given that approximately 40% of HCC patients exhibit AFP negativity (≤20 ng/mL), abdominal ultrasound demonstrates limited sensitivity in the early detection of HCC, and liver tissue biopsy is associated with high cost and risk in clinical practice, the early diagnosis of HCC continues to encounter substantial challenges (6–8). Here, AFP is linked to hepatocellular carcinoma.